WebAug 1, 2011 · Chad Heatwole, Associate Professor of Neurology, University of Rochester: ClinicalTrials.gov Identifier: NCT01406873 Other Study ID Numbers: 3716 Funding Source: FDA/OOPD ( Other Grant/Funding Number: R01FD003716 ) First Posted: August 1, 2011 Key Record Dates: Results First Posted: March 29, 2024 ... WebMay 25, 2016 · Chad Heatwole receives grant funding from the NIH, FDA, and Cure SMA foundation. He is the founder and CEO of the Neuromuscular Quality of Life Institute. He receives royalties for the Myotonic Dystrophy Health Index. He reviews medical cases for Imedecs and Maximus. He provides consultation to Biogen and Atyr.
Patient-Reported Impact of Symptoms in Friedreich Ataxia
WebDr. Chad Heatwole, MD, is a specialist in internal medicine who treats patients in Rochester, NY. This provider has 22 years of experience and is affiliated with Rochester General Hospital. They accept 70 insurance plans. WebAuthors Chad R Heatwole 1 , Jill Miller , Bill Martens , Richard T Moxley 3rd Affiliation 1 Neuromuscular Disease Center, Strong Memorial Hospital, University of Rochester, 601 … michael zerlin thibodaux la
Dr. Chad Heatwole, MD, Neurology Specialist - Rochester, NY
WebApr 21, 2024 · This is a single-center, open-label study of daily human growth hormone (Genotropin®, 5.0 μg/kg via subcutaneous injection) and testosterone (testosterone enanthate, 140mg via intramuscular injection every two weeks) for 24 weeks in men with FSHD with a 12 week washout period. http://www.rochesterhealth.com/index.php/healthcaredirectory/profile/0542522855/dr-chad-r-heatwole-md-neurology WebJul 28, 2015 · Chad Heatwole: acquisition of data, analysis or interpretation of data, critical revision of the manuscript for important intellectual content. Shree Pandya: acquisition of data, analysis or interpretation of data, … how to change your user on discord